NOUL Co., Ltd.
Marie-Charlotte (Macha) Lenoir is a Business Development Manager at NOUL Co., Ltd. since February 2025, with prior experiences including Regional Business Manager at Bionano Genomics, Inc. and Responsable Grands Comptes at Beckman Coulter Diagnostics. Macha has a strong background in microbiology, having held various technical roles, including responsibilities at Arthrex and Greiner Bio-One North America, Inc. Macha's academic qualifications include a Master's degree in Microbiology/Marketing and a Master 1 and 2 in Applied Microbiology and Biological Engineering from Paris-Sud University. Extensive laboratory experience encompasses virology, microbiology, and molecular biology techniques.
This person is not in any teams
This person is not in any offices
NOUL Co., Ltd.
Noul Inc. has developed the next generation POC (Point-Of-Care) blood testing platform for resource-limited medical facilities, clinics, and local hospitals. Noul seeks to solve global challenges that threaten human life, to discover novel solutions, and to establish a new gold standard in POC blood testing. Noul’s solution aims to improve accessibility to proper health care by integrating innovations in biology, artificial intelligence, mobile technology, robotics, and software/hardware engineering. Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions. [Mission] We explore global challenges that threaten human health and life, discover novel potential solutions, and realize those possibilities. [Goal] 1. To contribute to eliminating malaria, tb, aids and other neglected diseases through innovative diagnostic platform. 2. To proactively increase healthcare accessibility through next-generation blood diagnostics platform.